Summary of Product Characteristics
last updated on the eMC:
04/11/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 04/11/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Oct-2011 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
In section 4.2: (Posology and Method of Administration): An alternative titration strategy has been added
In Section 4.8 (Undesirable Side Effects)- Information on titration reducing the incidence and severity of flu-like symptoms has been included
In Dection 10 (Revision of Date of Text)- Date amended
|
|
Updated on 30/06/2011 and displayed until 04/11/2011
|
Reasons for adding or updating:
|
|
|
| Date of revision of text on the SPC: |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
